Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz
- Address
- Ul. Stanislawa Staszica 17/a, 35051 Rzeszcow, Poland
Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz - Respiratory Medicine Research
Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz is a specialized medical practice dedicated to advancing respiratory medicine through clinical research. The center focuses on investigating innovative therapeutic approaches for patients with chronic respiratory conditions, with particular emphasis on optimizing treatment strategies and improving patient outcomes.
- Asthma management and rescue medication optimization
- Comparative efficacy studies of inhalation therapies
- Prevention of severe clinical asthma exacerbations
The practice has established expertise in conducting controlled clinical trials evaluating novel bronchodilator and corticosteroid combination therapies. Their research portfolio includes investigations into fluticasone propionate and albuterol sulfate formulations delivered through advanced inhalation devices, contributing valuable evidence to support improved asthma rescue medication protocols and helping to reduce the burden of severe exacerbations in affected patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma | Chiesi Farmaceutici S.p.A. | Phase II | Not Recruiting | Nov 2023 | Dec 2025 |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Formoterol Fumarate Dihydrate | 2 | Unknown | 2021-04-29 | 2024-01-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.